Elevated ARPC1B was identified in 57 (38%) of the tumor samples, significantly higher compared to only 4 cases (13%) in matched non-tumorous tissues (OR = 0.2510; 95% CI: 0.09093–0.7292; p = 0.009; Fig. A2). This evidence concerns the gene ARPC1B and neoplasm.